{
    "id": 6903,
    "name": "eye lymphoma",
    "source": "DOID",
    "definition": "A lymphoma by site that is manifested in immune system cells called lymphocytes. [url:http\\://www.cancer.org/docroot/cri/content/cri_2_4_1x_what_is_eye_cancer_74.asp]",
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        
    ],
    "termId": "DOID:6903",
    "evidence": [
        
    ],
    "clinicalTrials": [
        {
            "nctId": "NCT03964090",
            "title": "Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R) in Aggressive B-cell Lymphomas With Secondary Involvement of the Central Nervous System (CNS)",
            "phase": "Phase II",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 8428,
                    "therapyName": "Cytarabine + Dexamethasone + Etoposide + Isavuconazole + Pegylated liposomal-doxorubicin + Rituximab + Temozolomide",
                    "synonyms": null
                },
                {
                    "id": 8429,
                    "therapyName": "Cytarabine + Dexamethasone + Etoposide + Ibrutinib + Isavuconazole + Pegylated liposomal-doxorubicin + Rituximab + Temozolomide",
                    "synonyms": null
                }
            ]
        }
    ]
}